SmarterDividends
NVO

Novo Nordisk A/S

NVO

Healthcare · Stock · semiannual payer

$43.24

Undervalued · +72% Add to Portfolio

Forward Yield

4.15%

Annual Dividend

$1.80

Payout Ratio

44%

5-Yr Growth

20.9%

Ex-Date

Aug 17, 2026

Frequency

Semiannual

Summary

As of September 2026, Novo Nordisk A/S (NVO) yields 4.15% ($1.80 per share annually), with a blended fair-value estimate of $74.35 — +72% upside, so it screens as undervalued. Dividend safety grade: B (71/100). 7 years of dividend growth.

Is NVO a good dividend stock?

Yes, with caveats

Novo Nordisk A/S (NVO) pays a semiannual dividend yielding 4.15% ($1.80/yr), with 7 years of growth and a dividend-safety grade of B. It's a solid income payer, but check the caveats below before buying.

Advantages

  • Comfortable payout ratio (44%)
  • Strong 20.9% 5-yr dividend growth

Risks

  • Cut its dividend in 2017
  • Share price is down over the past 5 years

Key Data

Dividend Yield
4.15%
Payout Ratio
44%
Annual Dividend
$1.80
5-Yr Avg Growth
20.9%
Ex-Dividend Date
Aug 17, 2026
Years of Growth
7
Frequency
semiannual
Beta
0.34
Market Cap
$191.0B
P/E Ratio
10.7
5-Yr Total Return
-21%
52-Week Range
$35.12 – $64.16
Dividend Safety
B · 71/100
Ever Cut?
Yes (2017)
NVO ex-dividend date & scheduleNext ex-date Aug 17, 2026 · full ex-dividend historyView →

Frequently Asked Questions